Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
HSPB1
REST API REST API
Homo sapiens
HSPB1 is differentially expressed in 317 experiments: 151 organism parts: bone marrow, cerebellum, ... (149 more);, 223 disease states: normal, control, ... (221 more);, 98 cell types 427 cell lines 41 compound treatments and 76 other conditions.
Synonyms Hsp25, Hs.76067, HSP27, HSP28
Orthologs E1BEL7_BOVIN (Bos taurus)   Hspb1 (Rattus norvegicus)   F6RRK4_CIOIN (Ciona intestinalis)   Hspb1 (Mus musculus)   F1P593_CHICK (Gallus gallus)   l(2)efl (Drosophila melanogaster)   hspb1 (Danio rerio)   hspb1 (Xenopus laevis)   HSPB1_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term angiogenesis, cytosol, plasma membrane, proteasome complex, protein binding, cytoskeleton, cytoplasm, cellular component movement, intracellular, negative regulation of protein kinase activity, negative regulation of apoptosis, RNA metabolic process, response to stress, regulation of translational initiation, insoluble fraction, anti-apoptosis, response to unfolded protein, soluble fraction, contractile fiber, spindle, nucleus, cell death, regulation of I-kappaB kinase/NF-kappaB cascade, cell surface, ubiquitin binding, Z disc, protein kinase C inhibitor activity, mRNA metabolic process, blood vessel endothelial cell migration, response to virus, negative regulation of phosphorylation, positive regulation of tumor necrosis factor biosynthetic process, positive regulation of interleukin-1 beta production, negative regulation of protein serine/threonine kinase activity, protein kinase C delta binding, endothelial cell chemotaxis, cellular response to vascular endothelial growth factor stimulus
InterPro Term Hsp20, Alpha-crystallin/HSP
UniProt Accession C9J3N8, P04792, B4DL87, F8WE04
Gene-Disease Assocation NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B, CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F
Search EB-eye ENSG00000106211
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-1577, E-GEOD-7540, E-GEOD-3526, ... (27 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, ... (43 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-5258, E-MTAB-37, E-GEOD-24147
SW480
1
3
E-MEXP-1014, E-GEOD-2509, E-GEOD-18005, E-MTAB-37
BT-474
2
E-GEOD-3529, E-GEOD-5823
MCF-10A
2
E-TABM-420, E-GEOD-14990
MCF-7
2
E-GEOD-20081, E-GEOD-5823
MOLT4
2
E-MTAB-62, E-MTAB-37
421 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-500, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, ... (51 experiments)

Factor Value U/D Experiments
monocyte
1
5
E-GEOD-5099, E-GEOD-995, E-MEXP-2019, E-GEOD-8286, E-GEOD-22373, ... (6 experiments)
bronchial epithelial
2
E-AFMX-5, E-MTAB-25
fibroblast
1
2
E-GEOD-3204, E-GEOD-26672, E-GEOD-3920
erythropoietic
1
E-GEOD-9894
bone marrow CD34+ cell
1
E-GEOD-500
immortalized cell culture
1
E-GEOD-14990
92 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-GEOD-12254, E-GEOD-16363, ... (63 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-MEXP-2034, E-TABM-26, E-MTAB-62, E-MEXP-1327
control
1
4
E-GEOD-21912, E-GEOD-8121, E-GEOD-20602, E-GEOD-3185, E-GEOD-16728 ... (5 experiments)
lung adenocarcinoma
1
3
E-MEXP-231, E-MTAB-62, E-GEOD-2514, E-MTAB-37
hepatocellular carcinoma
2
E-TABM-36, E-MTAB-62
adrenocortical carcinoma
2
E-GEOD-10927, E-TABM-311
choriocarcinoma
2
E-MTAB-37, E-MTAB-62
217 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5741, E-GEOD-697, E-TABM-782, E-GEOD-3720, ... (26 experiments)

Factor Value U/D Experiments
none
3
8
E-GEOD-5099, E-TABM-868, E-TABM-782, E-MEXP-1601, E-GEOD-4600, ... (11 experiments)
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
phorbol 12-myristate 13-acetate + ionomycin
1
E-GEOD-3720
M-CSF
1
E-GEOD-5099
unknown
1
E-GEOD-7307
vanadium pentoxide
1
E-GEOD-5339
35 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, ... (11 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-2034, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-2171

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, E-MEXP-2283, E-MTAB-62 ... (5 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-89, E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, ... (8 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720, E-GEOD-4086

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-MEXP-1437, E-GEOD-17476, E-TABM-868, E-MEXP-583, E-MEXP-1403, ... (13 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-GEOD-20540, E-GEOD-10315, E-TABM-440, ... (14 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-MEXP-2069, E-GEOD-1926, ... (37 experiments)

Infection
studied in E-GEOD-12254, E-MEXP-561, E-GEOD-6802

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977

Karyotype
studied in E-GEOD-12662

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism status
studied in E-GEOD-19188

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Phenotype
studied in E-GEOD-21750, E-GEOD-17636, E-GEOD-4600, E-MEXP-1403

Population
studied in E-MTAB-197, E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19246, ... (6 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-18791, E-GEOD-10896, E-GEOD-17204

RNAi
studied in E-GEOD-12438, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, ... (8 experiments)

Sample preparation
studied in E-GEOD-16728

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-21909, E-GEOD-19246, E-GEOD-19815, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561

Tumor size
studied in E-GEOD-8167

Vehicle
studied in E-GEOD-5258

Processing time: 0.448 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM